OBS! Ansökningsperioden för denna annonsen har
passerat.
Arbetsbeskrivning
Recipharm Development in Uppsala is one of Recipharm’s development facilities. The site is located in Uppsala, Sweden.
Recipharm Development in Uppsala has extensive experience in medicinal chemistry. The offering includes a wide array of services in chemical synthesis and analysis including some very demanding specialties such as ADC offerings, radiolabelling and non-GMP scale up chemistry. The company also offers GLP and non-GLP Bioanalytical services as well as autoradiography and pre-formulation services.
For the analytical Laboratory in Uppsala we are now searching for a motivated analytical chemist.
Work description
The work will include method development and validation as well as method and instrument troubleshooting. You will be working closely with other analytical and synthetic chemists in your projects, but will be expected to independently perform all project tasks from method development to report writing. Your tasks will vary to include both quantitative and qualitative challenges and will always include laborative work. The laboratory is equipped with UPLC, HPLC, GC, UV, FL, MS, MS/MS, TOF instruments which you can use in your projects.
Development of HPLC-UV and HPLC-MS analytical methods for qualitative and quantitative purposes.
Perform the analytical work with your developed methods and report both internally and to external customers in English and Swedish.
Qualifications
Solid experience in quantitative and/or qualitative analytical chemistry with previous experience in academia or the industry.
Good, practical laboratory skills centred around chromatography
Good English and Swedish skills, both verbal and written.
The position
We are offering a permanent, full time position starting with a 6 months trial period. Recipharm Development in Uppsala has its laboratory situated in Uppsala Business Park in Uppsala.
Apply for the position by the link below, no later than September 28th 2016.
About Recipharm
Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 3,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 5.0 billion and the Company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.
For more information on Recipharm and our services, please visit www.recipharm.com